Carlsmed, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.7Mgeneral payments (2019-2025)
$271Kresearch payments (2019-2025)
931clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2021 $12K
2022 $149K
2023 $356K
2024 $437K
2025 $753K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurological Surgery $917K
Orthopaedic Surgery of The Spine $401K
Orthopaedic Surgery $277K
Cardiovascular Disease $51K
Sports Medicine (Orthopaedic Surgery) $19K
Physician Assistant $15K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Justin Smith Charlottesville, VA Neurological Surgery $184,639.65
Joseph Osorio San Diego, CA Neurological Surgery $128,031.47
Christopher Ames San Francisco, CA Neurological Surgery $117,405.55
Roland Kent Post Falls, ID Orthopaedic Surgery of The Spine $101,690.01
John Small Temple Terrace, FL Orthopaedic Surgery $63,364.36
Saeed Sadrameli Kissimmee, FL Neurological Surgery $55,442.13
Brian Handal West Des Moines, IA Orthopaedic Surgery of The Spine $54,263.01
Jahangir Asghar Plantation, FL Orthopaedic Surgery of The Spine $53,036.06
Eric Topol La Jolla, CA Cardiovascular Disease $50,896.00
Sigurd Berven San Francisco, CA Orthopaedic Surgery $44,133.13

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.